Boston, MA 07/25/2014 (wallstreetpr) – Boston Scientific Corporation (NYSE:BSX) has acquired CE mark, a European Union approval, for its latest product Ranger™ Drug Coated Balloon (RDCB) used in treatment of peripheral artery disease (PAD). This product enables physicians to treat PAD related diseases by delivering the anti stenotic drug to vascular tissue without leaving any permanent implant. Simply put, the drug is absorbed totally by the tissue instead of having some part of the drug being lost in insertion or delivery device. The RDCB is now available all over the Europe bringing respite to both physicians and patients affected by PAD.
CE mark for new 25mm Lotus™ Valve System
Complementing its already existing 23mm and 27mm valve sizes, Boston Scientific Corporation (NYSE:BSX) has received the CE mark for its innovate 25mm Lotus™ Transcatheter Aortic Valve Implantation (TAVI) System. Thus, physicians have an increased range of TAVI systems to choose from. Trials of the 25 mm TAVI system have been successfully evaluated in select hospitals in Europe and Australia before its launch. The physicians are excited about the flexibility and the precision that 25mm TAVI system has got to offer in treating aortic valve disease faced by certain percentage of population aged over 65 years.
Launching POLARIS™ Imaging System
Boston Scientific Corporation (NYSE:BSX) launched POLARIS™, an image processing system to guide physicians to better process information from its suite of products that include intravascular ultrasound catheters and coronary, peripheral and intra-cardiac echo products. The Polaris system is designed to be fast and accurate, in the process helping to make much more reliable and efficient clinical decisions and procedures to happen. Boston Scientific received CE mark and Federal Drug Administration (FDA) approval for this state of the art Image Processing System.
An FDA Approval
Boston Scientific Corporation (NYSE:BSX) has been grant approval by the Federal Drug Administration (FDA) for its latest product REBEL™ Platinum Chromium Coronary Stent System. This product is company’s latest innovation in bare-metal stents that continue to play critical role in treating coronary artery disease (CAD). Of the suite of stent systems that Boston Scientific has to offer, the Rebel stent is uniquely designed with platinum chromium alloy with customized architecture.
